Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline vs. Nicotine Patch for Smoking Cessation
NCT00143325Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Pfizer. Primary endpoint: Continuous abstinence for the last 4 weeks of varenicline and NRT (Nicotine Replacement Therapy) treatment period. Started Jan 2005; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00143325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143325.